Pulmonary Pharmacology & Therapeutics

Papers
(The H4-Index of Pulmonary Pharmacology & Therapeutics is 16. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Myricetin inhibits TNF-α-induced inflammation in A549 cells via the SIRT1/NF-κB pathway58
The immunomodulatory effects of macrolide antibiotics in respiratory disease56
Sequential doxycycline and colchicine combination therapy in Covid-19: The salutary effects53
Antihistamines and azithromycin as a treatment for COVID-19 on primary health care – A retrospective observational study in elderly patients40
Tofacitinib reduces mortality in coronavirus disease 2019 Tofacitinib in COVID-1936
Glucagon-like peptide 1 receptor (GLP-1R) agonist relieved asthmatic airway inflammation via suppression of NLRP3 inflammasome activation in obese asthma mice model32
Small-molecule drugs for cystic fibrosis: Where are we now?31
The anti-inflammatory effects of cannabidiol and cannabigerol alone, and in combination31
Baicalin ameliorates cigarette smoke-induced airway inflammation in rats by modulating HDAC2/NF-κB/PAI-1 signalling27
Aerosolized Beractant in neonatal respiratory distress syndrome: A randomized fixed-dose parallel-arm phase II trial25
Guanosine and uridine alleviate airway inflammation via inhibition of the MAPK and NF-κB signals in OVA-induced asthmatic mice23
Effects of corticosteroids on Covid-19 patients: A systematic review and meta-analysis on clinical outcomes22
Gentiopicroside ameliorates ovalbumin-induced airway inflammation in a mouse model of allergic asthma via regulating SIRT1/NF-κB signaling pathway18
The inflammatory regulation of TRPA1 expression in human A549 lung epithelial cells17
Clofazimine for treatment of multidrug-resistant non-tuberculous mycobacteria17
CXCR1 correlates to poor outcomes of EGFR-TKI against advanced non-small cell lung cancer by activating chemokine and JAK/STAT pathway17
Chrysin prevents lipopolysaccharide-induced acute lung injury in mice by suppressing the IRE1α/TXNIP/NLRP3 pathway16
0.029470920562744